IMHO Even William give word 1st quarter will be better than last year But don't give too much hope on the Q1 He do mention there is 1 off expenses ( ESOS) Pls do some research before any buy / sell
I know got seasonal impact but if really want a good growth stock, then 1Q17 should be higher than 4Q16 also. Then can re-rate. Suspect results ok only, that is why price action ding dong or dong dong.
No worry for this counter. Why i say so, u refer to the short-term chart it show a uptrend, very slow trend and very strong support at 0.25/0.255..alsoo refer to historical chart, it undergo an uptrend between sept and mid of dec 2015...then b4 it up to 0.4 during 2016 there is a drop during dec 2015. So i jz predicted this operator use the same way to manage this counter. And now many good news for this counters but price still not yet move...if u know their signal u will no worry about it...jz wair fir the TP0. 35
Actually I have pass experience.Almost same like bioalpha right now.
During Jan I bought GPACKET at 0.29. But everyday operator purposely push it down 0.005 everyday, almost end trading of the day. They push until around 0.23. I keep on average my price, if that day price drop below my lowest purchase price I will buy some. This trend around 2 - 3weeks. After shoot up to 0.35 and continue to 0.4. I let go at 0.38. Anyone here have buy GPACKET before?
Now this happen in bioalpha, almost same as previous.look like purposely to push down. what I learn previous apply here as well. Hope this is same pattern.
So, what I said, set your own cut loss point. How much is your max amount can be loosed.
Why I mention must be positive. Investment is to make your life good for future. Not to make you suffer and worry everyday about the price drop until cant sleep. Then this will make you always have a bad day.
So remember to set ur own cut loss. Don’t influence by other people. Money can earn back future. Don’t worry. Have a nice day ya…
Me too negative? No lah, if negative then will be shouting sell sell. Can't expect to keep calling buy when price action is so weak. We need to tell responsible in our comments. :-D
Not that mean richard.. not saying u negative, we stay together here for so long, need support to each other. price will further push down today. hold until result come out and see the next movement is how.
Now everybody sure will feel sad, since we all put hope for this stock. Feel free to share with us if some body already sold out and cut loss. Let go through the hard time together.
I have read many materials on this company .. I genuinely believe it's a good company with potential by it's more for long term. For their nature of biz it takes a long time to see the changes in biz result
just to add on what MD Mr William say during AGM according to him , demand for herbal is encouraging they are now more focus on value added product for example , dry form of katchip fathimah may sell for rm100 , but if they process it into ready to consume form they can sell higher price ( this show how efficient management is trying to increase return for shareholder )
as mention , doing phase 2 land cleaning
they have now focus on 2 major clinical trial
1st is traditional medication in controlling type 2 diabetes mellitus
just for u all know , Type 2 diabetis mellitis is a chronic disease with no cure , only prevention and control the disease in other word , once u diagnose with T2DM , it will be with u until u die current treatment for T2DM is only insulin injection , oral hypoglycemic agent and dietary control
Mr william added that the trial for traditional medication in T2DM is very encouraging in just 3 years time they will have clinical trial in local hospital
so far in medical segment , there is very very few proven supplement / product will help in control blood glucose what I can say is almost none ! dont ask how i know , cuz I am working in KKM if this clinical trial successful , u can imagine how big is this business and the future is very bright as T2DM is worldwide chronic disease which bring alot of complication if blood sugar is deranged
2nd major clinical trial is traditional medication as a hormone replacement therapy for menopausal women some Post-menopausal symptoms eg flushing , body ache , agitation is common after women achieve menopause because of the imbalance of hormone supply Mr William added , their study had prove trad medication effective in increase estrogen level and play a role as hormone replacement therapy
in current market , to treat post menopausal symptoms we usually supply hormone replacement therapy eg estrogen to ease the symptoms of post menopausal this have bring alot of un-neccesary complication eg thrombosis , uterine cancer
hope this new traditional medication by bioalpha aided as natural source of estrogen replacement which reduce unwanted side effect of current hormone replacement therapy
for oversea market Mr william say will focus more on China market according to him , very huge potential they are not even fully export to whole west china ( this is very important) in this year ,they had just open up inner mongolia market ( good news as company very aggresive in expanding market )
for constant 17 outlet now almost every month there is a new outlet opening ( he bring up example of opening bangi branch recently and 2 more branch to be open soon as mention in annual report )
target 30 outlet of constant end of the year
they have just sign 20k of co-op member for ECONSTANT member / agent of econstant currently included PDRM He do make joke that dont be suprise next time if u see police officer selling bioalpha product to you :)
for those worry why indonesia market dropping this is because they facing lenghty product registration time with new factory opening , they had shorten the product registration time and they had obtain indonesia license recently ( call ?ukut ) to produce product like coffee , drink , powder form , sachet , liquid , capsule ( but not tablet form )
5 product so far in indonesia market and will be more in indonesia in future
aim to have 100 constant pharmacy outlet in whole malaysia to control all upstream , downstream and all retail market in pharmacy malaysia ( on par of caring )
above is not a buy / sell call do analyse urself to value this company worth to hold or not
Mr willaim is a very humble person answer all shareholder question patiently very glad i am able to attend this year AGM advise all shareholder to attend next year AGM to judge urself
actually the reason for me to invest in this stock is because of the quarter report that management prepared. U can see the explanation is very detailed and long if compare to other company where others used to use one or two standard sentences to layan... but i can see the content in Bioalpha is much more detailed and rich.. I am not sure who is the writer but i can feel the heart of the management.
B2. Prospects for the financial year ending 31 December 2017 On 10 January 2017, the Group completed the Rights Issue with Warrants exercise (which was 1.22 times oversubscribed) and successfully raised RM26.7 million. The proceeds are intended to be used to fund a series of growth plans over the next 2 years that, among others, include launching of 27 new products across all 3 key markets – Indonesia, China, and Malaysia, as well as expansion of the agriculture business operations, and upgrading of machineries. For the Indonesian market, the Group target to launch 6 new products in each of 2017 and 2018 respectively. Given the past track record in Indonesia, the Group are positive that the new products will generate interest in the market and stimulate new growth demand. Meanwhile, the production for the Indonesian market shall be supported by the Group’s new manufacturing facility in Kampar, Pekan Riau of Sumatra. By having the production facility in Indonesia, it will shorten the otherwise lengthy new product registration period, thereby enabling us to introduce more products in shorter time and grow the market share at a quicker pace. In China, progressive and aggressive marketing campaign and participation in trade exhibitions have proven effective with encouraging sales growth from this market. As part of the Group strategy to differentiate ourselves from competitors and to grow the Chinese market, the Group have identified new target market segment, that is, the Muslim-majority provinces such as Xinjiang, Qinghai, Shaanxi, and Gansu where the Group would leverage on “Halal” certified products and appeal to the Muslim population in these regions. The Group plan to introduce 5 new products this year for this market. For the Group domestic market, the Group will unveil approximately 5 new products in each of 2017 and 2018 respectively. This will enhance the current product offering at Constant pharmacy outlets and other major pharmacies. The Group is working diligently to grow the pharmacy business via franchising and have identified Kelantan, Johor and Kedah as the new target markets. Having focused a big part of 2016 on rebranding, refurbishing and market positioning activities, the Group intend to channel the efforts on expansion and branding activities this year in order to reap greater benefits in the future. As of to date, the Group have a new franchise opening in March 2017 in Bangi. On the agriculture side, the Group have begun Phase II land clearing of 879.5-acres in Pasir Raja, Dungun. The Group’s planting will include Tongkat Ali, Kacip Fatimah, Betik Sekaki, Lada Hitam, Assam Gelugor and Kunyit which are highly in demand. The Group have allocated RM8.5 million from the Rights Issue with Warrants proceeds for expansion of agriculture business operations which includes working capital for the extraction of herbs. The Group aim to complete planting over the next 24 months.
From this blog we like a big family, we share information to each other, especially is xiaoxiami. You really make a good job to update us, who stay far and not able to attend the AGM. All people here are friendly & helpful. I hope all of us can make money, Hope Company is continuing growth, and all of us continue to hold it. Maybe until one day share price is 1.00 or 2.00 in year 2018, 2019, 2020. Don’t scold me ya. This just a dream. I really wish to have a good return with all of you.
Introducing MY's First IPO Fund for Sophisticated Investors!
MQ Chat
New Update. Discover investment communities that resonate with your ideas
MQ Trader
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
0:17
New IPO: Building management systems (BMS), solar thermal systems and energy-saving services provider, Solar District Cooling Bhd aims to list on the Ace Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
richardlee
2,005 posts
Posted by richardlee > 2017-05-28 18:08 | Report Abuse
Surprised results not out after AGM. The price action however worries me a bit, results not as good as market expects?
Last time i complain it is a ding dong stock no going anywhere. I hope next week it does not become even worse and turn into a dong dong stock. :-D